Skip to main content
OpenTrials
Completed

NCT Number: NCT01379053

Volatile Organic Compounds in Staphylococcus Aureus Patients

The zNose® MRSA test is a non-invasive breath test for markers of Staphylococcus aureus, which may predict the probability of bacterial organisms in the anterior nares, throat and respiratory tract, wounds, and anus and therefore be able to replace or supplement current active Methicillin Resistant Staphylococcus Aureus (MRSA) surveillance efforts. It consists of:

* A collection apparatus for collection of volatile compounds from suspected infection sites onto a sorbent trap or Tedlar bag, as well as for the collection of a separate sample of room air. * Analysis of the volatile organic compounds from suspected infection sites and room air by short acoustic wave gas chromatography. * Interpretation of the volatile organic compounds with a proprietary algorithm in order to predict the probability of Staphylococcus aureus infection and colonization.

This study will test the hypothesis that we can identify the presence of MRSA by sampling the "head space" above culture media of anterior nare samples provided by patients with MRSA. Additionally, this study will test the hypothesis that we can identify the presence of MRSA by sampling air exhaled through the nostrils (nasal exhalant).

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ventura County Medical Center Hospital

Ventura, California, 93003, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Suspicion of staphylococcus aureus infection or colonization
  • Able to give samples for zNose® analysis

Exclusion criteria

  • Inability to provide sample for zNose® analysis

Treatment and study plan

Primary outcomes

  1. Identification of Methicillin Resistant Staphyloccus aureus

    Time frame: one week

    Identification during clinic visit of MRSA

Sponsors and collaborators

Lead sponsor

Landon Pediatric Foundation

Other

Registry information

Official study title

Detection of Methicillin Resistant Staphylococcus Aureus Colonization Using the zNose®, an Ultra-fast Gas Chromatograph

Acronym: MRSAVOC

Important dates

Study start
2009
Primary completion
2009
Study completion
2010
First posted
Jun 23, 2011
Registry last updated
Aug 13, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.